The recombinant protein market is estimated to be valued at US$ 3131.37 Mn in 2023 and is expected to exhibit a CAGR of 11.% over the forecast period from 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Recombinant proteins refer to proteins that are produced using genetic engineering techniques such as gene expression or protein purification. These proteins have commercial, medical and scientific applications and are useful in areas such as biopharmaceuticals, diagnostics and research. Common applications include biologics development, life science research, diagnostic kits and drugs.


Market Dynamics:
The recombinant protein market is driven by increasing spending on biopharmaceutical research and development. The biopharmaceutical industry relies heavily on recombinant proteins for discovery, preclinical and clinical research of biologics drugs. Further, rising demand for protein-based therapeutics such as monoclonal antibodies is also contributing to market growth. Monoclonal antibodies development requires the use of recombinant proteins as critical tools in cell line development and protein expression optimization. However, high costs associated with protein production and purity challenges are some of the factors hindering the market growth.

SWOT Analysis

Strength: The recombinant protein market is driven by increasing R&D investments in life science research. Advancements in gene cloning and genetic engineering techniques have simplified protein production processes. Recombinant proteins find numerous applications in pharmaceuticals, biotechnology and other industries.

Weakness: High costs associated with development and production of recombinant proteins can hamper market growth to some extent. Production challenges related to growth, purification and quality control of recombinant proteins also act as a barrier.

Opportunity: Untapped growth opportunities in emerging markets of Asia Pacific and Latin America will support the recombinant protein market expansion over the coming years. Increasing collaboration between biotech firms and academic institutions will also create new avenues.

Threats: Stringent regulations pertaining to transgenic crops and products may restrict the recombinant protein market up to a certain level. Intense competition among existing players also poses challenges.

Key Takeaways:

The global recombinant protein market forecast is expected to witness high growth, exhibiting CAGR of 11% over the forecast period, due to increasing R&D investments in life science research from pharmaceutical and biotech companies. Advances in molecular cloning and gene engineering techniques have accelerated protein production in bacterial, yeast, insect and mammalian expression systems.

Regional analysis

The North America recombinant protein market is projected to dominate other regions, owing to presence of major biopharma companies and availability of advanced research infrastructure. Asia Pacific recombinant protein market is poised to experience fastest growth, driven by rising biologics production in China, India, South Korea and other nations. Increasing collaborations between global players and regional research centers will further propel the APAC recombinant protein demand over the next few years.

Key players

Key players operating in the recombinant protein market are Merck KGaA, OriGene Technologies, Inc., Thermo Fisher Scientific Inc., Feldan Therapeutics, ACROBiosystems, Abcam plc., Randox Laboratories Ltd., SOL GROUP, Proteintech Group, Inc, Planet Biotechnology, Inc., INFINITE ENZYMES, INC., ORF Genetics, GenScript, BTL Biotechno Labs Pvt Ltd., Prospec-Tany Technogene Ltd., BPS Bioscience, Inc., Sino Biological, Cape Bio Pharms, Abnova Corporation, GeNext Genomics. These companies are focusing on new product launches, partnerships and strengthening of R&D capabilities to gain major revenue share in the global market

Get more insights on this topic: https://weblogmarketinsights.blogspot.com/2023/12/therapeutic-recombinant-proteins-is.html